Coromandel International Limited, the promoter of NACL Industries , has confirmed that it along with persons acting in concert has not created any encumbrance on the shares of the company during the financial year 2025-26. This disclosure ensures that the shareholding remains free from charges such as pledges or hypothecation, which is a key indicator of financial stability for investors. The confirmation was submitted to the stock exchanges on April 10, 2026, in compliance with regulatory requirements.

The filing was made pursuant to Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Coromandel International stated that neither the promoters nor the promoter group members have made any direct or indirect encumbrance on the shares during the specified financial year. The disclosure was simultaneously provided to the Audit Committee of NACL Industries in accordance with Regulation 31(5)(b) of the SEBI SAST Regulations.

Promoter and PAC Details

The disclosure included a comprehensive list of 199 entities classified as promoters or persons acting in concert (PAC). The list encompasses individuals, trusts, and corporate entities within the promoter group. Below is a summary of the key categories of entities identified in the filing.

The list also detailed numerous foreign subsidiaries and associates, such as Coromandel International (Nigeria) Limited and Coromandel Brasil Ltda, all classified under the promoter group. The confirmation was signed by B Shanmugasundaram, Company Secretary & Compliance Officer of Coromandel International Limited.

NACL Industries Limited has announced the convening of its 39th Annual General Meeting (AGM) on Wednesday, July 22, 2026, at 03:30 P.M. IST. The meeting will be held through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), with the registered office of the Company deemed to be the venue. The Company, established in 1993, has evolved into a diversified agrochemical company with a strong presence across domestic retail, institutional, and export markets, offering a portfolio of over 66 branded products spanning insecticides, herbicides, fungicides, and plant growth regulators.

AGM Key Details

The following table summarises the key logistics and agenda items for the 39th AGM:

AGM Agenda

The business to be transacted at the AGM includes both ordinary and special items:

Ordinary Business:

• Adoption of Audited Standalone Financial Statements for the financial year ended March 31, 2026, along with the Auditors' Report and Board of Directors' Report
• Adoption of Audited Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Auditors' Report
• Re-appointment of Mr. Sankarasubramanian S (DIN: 01592772), Non-Executive Director, who retires by rotation

Special Business:

• Ratification of remuneration of ₹8,00,000/- (Rupees Eight Lakhs only) plus applicable taxes payable to M/s. K. Narasimha Murthy & Co., Cost Auditors, for the financial year ending March 31, 2027
• Approval by Special Resolution of the revision in remuneration payable to Dr. Raghuram Devarakonda (DIN: 09749805), Managing Director & Chief Executive Officer, with effect from April 01, 2026

MD & CEO Remuneration Revision

The Board, on the recommendation of the Nomination and Remuneration Committee, approved a revision in the remuneration of Dr. Raghuram Devarakonda with effect from April 01, 2026. The key components of the revised remuneration structure are as follows:

Dr. Devarakonda's remuneration drawn during FY 2025-26 was ₹2,19,00,000.

FY 2025-26 Financial Performance

FY 2025-26 marked a significant turnaround for the Company. The acquisition of a majority stake by Coromandel International Limited strengthened stakeholder confidence, supported by a rights issue and improved credit ratings. The following table presents the consolidated financial performance:

The consolidated profit before exceptional items and taxes stood at ₹2,718 Lakhs, compared to a loss of ₹14,883 Lakhs in the previous year. Net profit after tax was ₹457 Lakhs against a loss after tax of ₹9,213 Lakhs in FY 2024-25.

Operating Results Summary

The Board's Report presented the following consolidated and standalone operating results for FY 2025-26 (₹ in Lakhs):

Key Corporate Developments in FY 2025-26

Several significant corporate events shaped the Company's trajectory during the year:

• Coromandel Acquisition: Coromandel International Limited (CIL) acquired 10,69,12,581 equity shares (53.08%) of NACL, making NACL a subsidiary of CIL with effect from August 8, 2025
• Rights Issue: The Company successfully mobilized approximately ₹249.29 Crores through a rights issue of 3,25,01,851 equity shares at ₹76.70 per share (face value ₹1, premium ₹75.70), allotted on December 31, 2025. Subsequent to the rights issue, CIL's stake increased to 53.73%
• Credit Rating Upgrade: Long-term bank facilities were upgraded to 'CRISIL AA/Stable' and short-term facilities to 'CRISIL A1+' as on November 07, 2025
• Share Capital: Paid-up equity share capital increased from ₹20,12,03,147 to ₹23,41,78,330 during the year

Business Segment Performance

The domestic retail business recorded 5% growth, with domestic retail sales of ₹67,742 Lakh against ₹64,266 Lakh in the previous year. Key segment highlights are as follows:

The international business expanded its footprint to 39 countries, recording export revenues of ₹35,355 Lakhs in FY 2025-26, a 14% year-on-year growth. Foreign exchange earned during the year was ₹35,355 Lakhs, while foreign exchange used was ₹31,370 Lakhs.

New Product Launches

During the year, the Company successfully commercialized manufacturing of the following new formulations:

Sustainability and Operations

The Srikakulam Technical Plant achieved annual production of 11,611 MT and the Dahej plant achieved 3,031 MT during the year. The Ethakota Formulation Unit recorded production of 23,220 MT/KL. The Company maintained Zero Liquid Discharge (ZLD) systems across all manufacturing facilities and received the Environment Excellence Award at the 19th ICC Environment Partnership Summit & Awards 2025 and the CII Andhra Pradesh Industrial Safety Excellence Award 2025.

The Company has set sustainability targets by 2030, including a 25% reduction in specific energy consumption, a 30% reduction in specific GHG/CO₂ emissions, a 25% increase in renewable energy utilization, a 25% reduction in specific hazardous waste generation, and a 30% reduction in specific water consumption. The average net profits for the immediately preceding three financial years resulted in a negative figure of ₹15.21 Lakhs, and accordingly no amount was spent towards CSR activities for FY 2025-26.

Site-wise Sustainability Performance

The following table presents sustainability metrics for the Ethakota site:

The Dahej facility demonstrated significant improvements across all major sustainability parameters:

Overall sustainability progress compared to the FY 2022 baseline is summarised below:

R&D Highlights

During the year, processes for four technical products were successfully developed, of which two were commercialized and two progressed to the pilot stage. The Company secured over 25 registrations across various categories in India, including three technical indigenous manufacturing registrations, and 10 registrations in international markets, taking the overall portfolio to 588 registrations domestically and 147 overseas. Three new patents were granted and approximately 21 new patent applications were filed. R&D expenditure for FY 2025-26 comprised capital expenditure of ₹134 Lakhs and revenue expenses of ₹1,761 Lakhs, representing 1.26% of total turnover.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE295D01020/311ac91ad52e4c64.pdf